| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.0069 | 1 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |